EUVIMEDEUVIMED entdecken
BeobachtungsstudieValidierungsstudieOpen Access

Development and Validation of a Predictive Model of Prostate Screening Compliance: A Nationwide Population‐Based Study

Diego Arriaga-Izabal iD, Francisco Morales-Lazcano iD, Adrian Canizalez-Román iD

The Prostate · 2025

DOI: 10.1002/pros.24854 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Prostate, 2025. Verfasst von Diego Arriaga-Izabal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Department, School of Medicine, Autonomous University of Sinaloa, Culiacan, México. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Early Detection of Cancer, Patient Compliance, Mass Screening. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prostate cancer (PCa) is the second most common cancer in men worldwide, with significant incidence and mortality, particularly in Mexico, where diagnosis at advanced stages is common. Early detection through screening methods such as digital rectal examination and prostate‐specific antigen testing is essential to improve outcomes. Despite current efforts, compliance with prostate screening (PS) remains low due to several barriers. This study aims to develop and validate a predictive model for PCa screening compliance in Mexican men. Materials and Methods Retrospective observational design with data from the Mexican Health and Aging Study (MHAS). Participants were men aged 50–69 from three cohorts: development/internal validation, temporal validation, and external validation. Key predictors were identified using relaxed Least Absolute Shrinkage and Selection Operator (LASSO) regression, and model performance was assessed using the area under the curve (AUC) from receiver operating characteristic (ROC) analyses, along with calibration and decision curve analysis (DCA). A web nomogram was also developed.

Results

The final model included seven key predictors. AUC values indicated good predictive performance: 0.783 for the training subgroup, 0.722 for the test subgroup, 0.748 for the time cohort, and 0.756 for the external cohort, with sensitivities of 73.5%. The DCA demonstrated the superior clinical utility of the model compared to the reference strategies.

Conclusions

The predictive model developed for performance to PCa screening is robust across different cohorts and highlights critical factors influencing performance. The accompanying web‐based nomogram enhances clinical applicability and supports interventions aimed at improving PCa screening rates among Mexican men.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsEarly Detection of CancerPatient ComplianceMass ScreeningHumansMaleAgedMiddle AgedRetrospective StudiesProstate-Specific AntigenMexicoNomograms

Stichwörter der Autor:innen

Mexicoearly detection of cancerpredictive modelprostate cancer

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Research Department, School of Medicine, Autonomous University of Sinaloa, Culiacan, México.

ORCID-Profile: Diego Arriaga-Izabal, Francisco Morales-Lazcano, Adrian Canizalez-Román

Förderung

  • NIA NIH HHS
  • The authors received no specific funding for this work.

Zitieren

APA

Arriaga-Izabal, D., Morales-Lazcano, F., & Canizalez-Román, A. (2025). Development and Validation of a Predictive Model of Prostate Screening Compliance: A Nationwide Population‐Based Study. The Prostate. https://doi.org/10.1002/pros.24854

Vancouver

Arriaga-Izabal D, Morales-Lazcano F, Canizalez-Román A. Development and Validation of a Predictive Model of Prostate Screening Compliance: A Nationwide Population‐Based Study. The Prostate. 2025. doi:10.1002/pros.24854

BibTeX
@article{ArriagaIzabal2025,
  author = {Arriaga-Izabal, Diego and Morales-Lazcano, Francisco and Canizalez-Román, Adrian},
  title = {Development and Validation of a Predictive Model of Prostate Screening Compliance: A Nationwide Population‐Based Study},
  journal = {The Prostate},
  year = {2025},
  doi = {10.1002/pros.24854}
}
Kostenlos starten →